Xiangxue Pharmaceutical (300147) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.069x

Based on the latest financial reports, Xiangxue Pharmaceutical (300147) has a cash flow conversion efficiency ratio of 0.069x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥75.64 Million ≈ $11.07 Million USD) by net assets (CN¥1.10 Billion ≈ $160.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Xiangxue Pharmaceutical (300147) market capitalisation for the company's overall valuation and market capitalisation.

Xiangxue Pharmaceutical - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Xiangxue Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Xiangxue Pharmaceutical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Xiangxue Pharmaceutical ranked by their cash flow conversion efficiency. Explore 300147 cash flow quality score to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
SEC Electric Mach Co Ltd SHG:603988	0.015x
Rongsheng Paper SHG:603165	-0.052x
TrueLight TWO:3234	-0.033x
Lotte Tour Dev KO:032350	-0.024x
ECN Capital Corp TO:ECN	-0.057x
Hangzhou Shenhao Technology Co Ltd SHE:300853	-0.083x
Hainan Haiqi Transportation Group Co Ltd SHG:603069	-0.017x
Wuhan Hvsen Biotechnology Co Ltd SHE:300871	0.025x

Annual Cash Flow Conversion Efficiency for Xiangxue Pharmaceutical (2007–2025)

The table below shows the annual cash flow conversion efficiency of Xiangxue Pharmaceutical from 2007 to 2025. View latest Xiangxue Pharmaceutical stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥43.95 Million ≈ $6.43 Million	CN¥139.63 Million ≈ $20.43 Million	3.177x	+25054.40%
2024-12-31	CN¥1.44 Billion ≈ $210.55 Million	CN¥18.17 Million ≈ $2.66 Million	0.013x	-88.91%
2023-12-31	CN¥2.31 Billion ≈ $338.50 Million	CN¥263.44 Million ≈ $38.55 Million	0.114x	+41.15%
2022-12-31	CN¥2.82 Billion ≈ $412.39 Million	CN¥227.38 Million ≈ $33.27 Million	0.081x	+17.71%
2021-12-31	CN¥3.76 Billion ≈ $549.88 Million	CN¥257.56 Million ≈ $37.69 Million	0.069x	+13.35%
2020-12-31	CN¥4.25 Billion ≈ $622.35 Million	CN¥257.18 Million ≈ $37.63 Million	0.060x	+199.49%
2019-12-31	CN¥4.11 Billion ≈ $601.66 Million	CN¥83.02 Million ≈ $12.15 Million	0.020x	-11.21%
2018-12-31	CN¥4.01 Billion ≈ $587.12 Million	CN¥91.24 Million ≈ $13.35 Million	0.023x	-19.37%
2017-12-31	CN¥3.88 Billion ≈ $568.31 Million	CN¥109.53 Million ≈ $16.03 Million	0.028x	-47.65%
2016-12-31	CN¥3.68 Billion ≈ $539.14 Million	CN¥198.48 Million ≈ $29.04 Million	0.054x	+19.47%
2015-12-31	CN¥3.55 Billion ≈ $518.89 Million	CN¥159.89 Million ≈ $23.40 Million	0.045x	-49.04%
2014-12-31	CN¥1.87 Billion ≈ $273.82 Million	CN¥165.58 Million ≈ $24.23 Million	0.088x	-53.92%
2013-12-31	CN¥1.71 Billion ≈ $250.23 Million	CN¥328.37 Million ≈ $48.05 Million	0.192x	+148.14%
2012-12-31	CN¥1.54 Billion ≈ $224.85 Million	CN¥118.91 Million ≈ $17.40 Million	0.077x	+271.56%
2011-12-31	CN¥1.42 Billion ≈ $207.64 Million	CN¥29.55 Million ≈ $4.32 Million	0.021x	-37.21%
2010-12-31	CN¥1.37 Billion ≈ $200.56 Million	CN¥45.47 Million ≈ $6.65 Million	0.033x	-75.75%
2009-12-31	CN¥337.62 Million ≈ $49.41 Million	CN¥46.19 Million ≈ $6.76 Million	0.137x	-51.75%
2008-12-31	CN¥196.54 Million ≈ $28.76 Million	CN¥55.72 Million ≈ $8.15 Million	0.284x	-60.67%
2007-12-31	CN¥191.45 Million ≈ $28.02 Million	CN¥138.02 Million ≈ $20.20 Million	0.721x	--

About Xiangxue Pharmaceutical

SHE:300147 China Biotechnology

Market Cap

$631.88 Million

CN¥4.32 Billion CNY

Market Cap Rank

#11149 Global

#3113 in China

Share Price

CN¥6.53

Change (1 day)

+1.08%

52-Week Range

CN¥6.25 - CN¥11.18

All Time High

CN¥25.81